TVTX logo

Travere Therapeutics (TVTX) Long term debt

Annual long term debt:

$327.50M-$72.37M(-18.10%)
December 31, 2024

Summary

  • As of today (July 1, 2025), TVTX annual long term debt is $327.50 million, with the most recent change of -$72.37 million (-18.10%) on December 31, 2024.
  • During the last 3 years, TVTX annual long term debt has risen by +$69.42 million (+26.90%).
  • TVTX annual long term debt is now -18.75% below its all-time high of $403.06 million, reached on December 31, 2022.

Performance

TVTX Long term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXbalance sheet metrics

Quarterly long term debt:

$326.25M-$1.26M(-0.38%)
March 31, 2025

Summary

  • As of today (July 1, 2025), TVTX quarterly long term debt is $326.25 million, with the most recent change of -$1.26 million (-0.38%) on March 31, 2025.
  • Over the past year, TVTX quarterly long term debt has dropped by -$72.73 million (-18.23%).
  • TVTX quarterly long term debt is now -19.40% below its all-time high of $404.77 million, reached on March 31, 2022.

Performance

TVTX Quarterly long term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXbalance sheet metrics

Long term debt Formula

Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt

TVTX Long term debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-18.1%-18.2%
3 y3 years+26.9%-19.4%
5 y5 years+59.9%+57.3%

TVTX Long term debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-18.8%+26.9%-19.3%at low
5 y5-year-18.8%+59.9%-19.4%+55.4%
alltimeall time-18.8%+656.6%-19.4%+653.7%

TVTX Long term debt History

DateAnnualQuarterly
Mar 2025
-
$326.25M(-0.4%)
Dec 2024
$327.50M(-18.1%)
$327.50M(-0.3%)
Sep 2024
-
$328.54M(-17.5%)
Jun 2024
-
$398.06M(-0.2%)
Mar 2024
-
$398.98M(-0.2%)
Dec 2023
$399.88M(-0.8%)
$399.88M(-0.2%)
Sep 2023
-
$400.70M(-0.2%)
Jun 2023
-
$401.51M(-0.2%)
Mar 2023
-
$402.30M(-0.2%)
Dec 2022
$403.06M(+56.2%)
$403.06M(-0.1%)
Sep 2022
-
$403.38M(-0.2%)
Jun 2022
-
$404.05M(-0.2%)
Mar 2022
-
$404.77M(+56.8%)
Dec 2021
$258.08M(+5.9%)
$258.08M(+15.4%)
Sep 2021
-
$223.70M(+1.3%)
Jun 2021
-
$220.86M(+1.3%)
Mar 2021
-
$218.08M(-10.5%)
Dec 2020
$243.68M(+18.9%)
$243.68M(+14.6%)
Sep 2020
-
$212.65M(+1.3%)
Jun 2020
-
$210.01M(+1.3%)
Mar 2020
-
$207.41M(+1.2%)
DateAnnualQuarterly
Dec 2019
$204.86M(+5.0%)
$204.86M(+1.2%)
Sep 2019
-
$202.35M(+1.2%)
Jun 2019
-
$199.89M(+1.2%)
Mar 2019
-
$197.47M(+1.2%)
Dec 2018
$195.09M(+332.8%)
$195.09M(+1.2%)
Sep 2018
-
$192.75M(+326.1%)
Mar 2018
-
$45.24M(+0.4%)
Dec 2017
$45.08M(+1.5%)
$45.08M(+0.4%)
Sep 2017
-
$44.91M(+0.4%)
Jun 2017
-
$44.75M(+0.4%)
Mar 2017
-
$44.58M(+0.4%)
Dec 2016
$44.42M(+1.5%)
$44.42M(+0.4%)
Sep 2016
-
$44.26M(+0.4%)
Jun 2016
-
$44.09M(+0.4%)
Mar 2016
-
$43.93M(+0.4%)
Dec 2015
$43.77M(+1.1%)
$43.77M(+0.0%)
Sep 2015
-
$43.75M(+0.4%)
Jun 2015
-
$43.59M(-48.3%)
Mar 2015
-
$84.24M(+94.6%)
Dec 2014
$43.29M
$43.29M(-48.0%)
Sep 2014
-
$83.29M(+0.6%)
Jun 2014
-
$82.81M

FAQ

  • What is Travere Therapeutics annual long term debt?
  • What is the all time high annual long term debt for Travere Therapeutics?
  • What is Travere Therapeutics annual long term debt year-on-year change?
  • What is Travere Therapeutics quarterly long term debt?
  • What is the all time high quarterly long term debt for Travere Therapeutics?
  • What is Travere Therapeutics quarterly long term debt year-on-year change?

What is Travere Therapeutics annual long term debt?

The current annual long term debt of TVTX is $327.50M

What is the all time high annual long term debt for Travere Therapeutics?

Travere Therapeutics all-time high annual long term debt is $403.06M

What is Travere Therapeutics annual long term debt year-on-year change?

Over the past year, TVTX annual long term debt has changed by -$72.37M (-18.10%)

What is Travere Therapeutics quarterly long term debt?

The current quarterly long term debt of TVTX is $326.25M

What is the all time high quarterly long term debt for Travere Therapeutics?

Travere Therapeutics all-time high quarterly long term debt is $404.77M

What is Travere Therapeutics quarterly long term debt year-on-year change?

Over the past year, TVTX quarterly long term debt has changed by -$72.73M (-18.23%)
On this page